Severe Falciparum and Vivax Malaria on the Thailand-Myanmar Border: A Review of 1503 Cases

Abstract Background The northwestern border of Thailand is an area of low seasonal malaria transmission. Until recent successful malaria elimination activities, malaria was a major cause of disease and death. Historically the incidences of symptomatic Plasmodium falciparum and Plasmodium vivax malar...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases Vol. 77; no. 5; pp. 721 - 728
Main Authors: Chu, Cindy S, Stolbrink, Marie, Stolady, Daniel, Saito, Makoto, Beau, Candy, Choun, Kan, Wah, Tha Gay, Mu, Ne, Htoo, Klay, Nu, Be, Keereevijit, Arunrot, Wiladpaingern, Jacher, Carrara, Verena, Phyo, Aung Pyae, Lwin, Khin Maung, Luxemburger, Christine, Proux, Stephane, Charunwatthana, Prakaykaew, McGready, Rose, White, Nicholas J, Nosten, François
Format: Journal Article
Language:English
Published: US Oxford University Press 05.05.2023
Subjects:
epidemiology
severe malaria
Severe malaria
Plasmodium falciparum
Plasmodium vivax
Epidemiology
ISSN:1058-4838, 1537-6591, 1537-6591
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background The northwestern border of Thailand is an area of low seasonal malaria transmission. Until recent successful malaria elimination activities, malaria was a major cause of disease and death. Historically the incidences of symptomatic Plasmodium falciparum and Plasmodium vivax malaria were approximately similar. Methods All malaria cases managed in the Shoklo Malaria Research Unit along the Thailand-Myanmar border between 2000 and 2016 were reviewed. Results There were 80 841 consultations for symptomatic P. vivax and 94 467 for symptomatic P. falciparum malaria. Overall, 4844 (5.1%) patients with P. falciparum malaria were admitted to field hospitals, of whom 66 died, compared with 278 (0.34%) with P. vivax malaria, of whom 4 died (3 had diagnoses of sepsis, so the contribution of malaria to their fatal outcomes is uncertain). Applying the 2015 World Health Organization severe malaria criteria, 68 of 80 841 P. vivax admissions (0.08%) and 1482 of 94 467 P. falciparum admissions (1.6%) were classified as severe. Overall, patients with P. falciparum malaria were 15 (95% confidence interval, 13.2–16.8) times more likely than those with P. vivax malaria to require hospital admission, 19 (14.6–23.8) times more likely to develop severe malaria, and ≥14 (5.1–38.7) times more likely to die. Conclusions In this area, both P. falciparum and P. vivax infections were important causes of hospitalization, but life-threatening P. vivax illness was rare. Among 94 467 patients with Plasmodium falciparum and 80 841 with Plasmodium vivax malaria, patients with P. falciparum were 15 times more likely to require hospital admission, 19 times more likely to develop severe malaria, and 14 times more likely to die.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1058-4838
1537-6591
1537-6591
DOI:10.1093/cid/ciad262